top of page
31/7/19
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients
Nicolè S, Lanzafame M, Lattuada E, Luise D, Vecchi M, Tacconelli E, Vento S.
To the Editor,
Recently in this journal, detailed Swedish recommendations on antiviral treatment of HIV infection were published, including management of adverse effects of the therapy. We here contribute with our experience on a beneficial effect of Efavirenz dose reduction on the lipid profile...
bottom of page